News
Company Overview: AUTM is the nonprofit leader in efforts to educate, promote and inspire professionals – throughout their careers – to support the development of academic research that changes the world. AUTM’s community is comprised of more than 3,000 members who work in more than 800 universities
Traumatic Brain Injuries (TBI) are a major cause of death and disability. Current therapies to treat TBIs with neuroprotective agents are often limited by ability to achieve therapeutic concentrations of the therapeutic agent in the brain. Inventors at the National Institute of Neurological
Primary mediastinal B-cell lymphoma (PMBCL) is a non-Hodgkin lymphoma that accounts for 5-7% of all aggressive lymphomas. Diagnosing PMBCL can be challenging as the features overlap with diffuse large B-cell lymphoma (DLBCL), another type of non-Hodgkin lymphoma. These two lymphomas respond
Researchers at the National Cancer Institute (NCI) have developed a diagnostic assay that detects sequence-specific (viral) RNA. This technology describes an RNase-H-assisted detection assay for RNA (RADAR) that is rapid, inexpensive, and highly sequence-specific. There is a great need for this